Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Henrik Andreas Bergrem"'
Autor:
Hallvard Holdaas, Geir Mjøen, Henrik Andreas Bergrem, Karsten Midtvedt, Ingar Holme, Ole Øyen, Per Fauchald
Publikováno v:
Transplant International. 24:73-77
Summary It is considered safe to donate a kidney if internationally accepted medical criteria are fulfilled. However, some donors have encountered hypertension, proteinuria and impaired renal function after donation. The study was based on retrospect
Autor:
Tone Gretland Valderhaug, Torbjørn Leivestad, Henrik Andreas Bergrem, Anders Hartmann, Jøran Hjelmesæth, Trond Jenssen, Harald Bergrem
Publikováno v:
Clinical Journal of the American Society of Nephrology. 5:616-622
Guidelines recommend that candidates for kidney transplantation (KTx) who do not have diabetes perform a pretransplantation oral glucose tolerance test (OGTT) when fasting plasma glucose (FPG) is110 mg/dl (6.1 mmol/L); however, the OGTT is potentiall
Autor:
Trond Jenssen, Tone Gretland Valderhaug, Henrik Andreas Bergrem, Jøran Hjelmesæth, Anders Hartmann, Harald Bergrem
Publikováno v:
Nephrology Dialysis Transplantation. 25:985-992
Background. Renal insufficiency predisposes to insulin resistance, hyperparathyroidism and derangements in calcium phosphate and nitrogenous compound balance, leading to pre-transplant hyperglycaemia. These metabolic risk factors are not fully correc
Autor:
Tone Gretland Valderhaug, Henrik Andreas Bergrem, Trond Jenssen, Jo Røislien, Anders Hartmann, Pål-Dag Line, Torbjørn Leivestad, Jøran Hjelmesæth
Publikováno v:
Diabetologia
Aims/objective: We aimed to assess the long-term effects of post-transplant glycaemia on long-term survival after renal transplantation. Methods: Study participants were 1,410 consecutive transplant recipients without known diabetes who underwent an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f37882e2b5b9f485cf9b7bd52190b85f
https://hdl.handle.net/10037/3741
https://hdl.handle.net/10037/3741
Publikováno v:
Therapeutic drug monitoring. 30(5)
Prednisolone may cause hyperglycemia after organ transplantation. Even at comparable weight-adjusted doses, prednisolone side effects vary considerably between individuals, suggesting between-patient pharmacokinetic differences. In renal transplant p
Publikováno v:
Diabetes Care. 35:e26-e26
We read with interest the article by Chakkera et al. (1), which presented a pretransplant risk score to help identify subjects who might develop new-onset diabetes after kidney transplantation (NODAT). Although the authors briefly discussed the limit